Yu Jung Shin

Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis

Inês Godet, Yu Jung Shin, Julia A. Ju et al. · Nature Communications · 2019 · 284 citations · Full text

Medicine, Cancer Biology, Oncology +17

3D bioprinting of mechanically tuned bioinks derived from cardiac decellularized extracellular matrix

Yu Jung Shin, Ryan T. Shafranek, Jonathan H. Tsui et al. · Acta Biomaterialia · 2020 · 168 citations

Engineering, Bioengineering, Biomedical Engineering +14

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin

Tae‐In Kam, Hyejin Park, Shih-Ching Chou et al. · Proceedings of the National Academy of Sciences · 2022 · 122 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Modified Early Warning Score Changes Prior to Cardiac Arrest in General Wards

Won Young Kim, Yu Jung Shin, Jin Mi Lee et al. · PLoS ONE · 2015 · 49 citations · Full text

Health Professions, Emergency Medicine, Patient Safety +15

Anti-Cancer Effect of Quercetin in Xenograft Models with EBV-Associated Human Gastric Carcinoma

Hwan Lee, Seulki Lee, Yu Jung Shin et al. · Molecules · 2016 · 47 citations · Full text

Medicine, Oncology, Pharmacology +14